LFWD – lifeward ltd. - ordinary shares (US:NASDAQ)
Stock Stats
News
Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval
Lifeward (NASDAQ:LFWD) had its price target lowered by analysts at HC Wainwright from $13.00 to $4.50. They now have a "buy" rating on the stock.
UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton
Lifeward Ltd. Reports Third Quarter 2025 Financial Results
Lifeward to Report Third Quarter Financial Results on November 14, 2025
Form DEF 14A Lifeward Ltd. For: Dec 01
Form PRE 14A Lifeward Ltd. For: Nov 21
Form 10-Q Lifeward Ltd. For: Sep 30
Form 8-K Lifeward Ltd. For: Nov 14
Form 8-K Lifeward Ltd. For: Oct 16
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.